Related references
Note: Only part of the references are listed.DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling
D. W. Chan et al.
ONCOGENE (2017)
Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways
Ohad Oren et al.
STEM CELL REVIEWS AND REPORTS (2017)
Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways
Ohad Oren et al.
STEM CELL REVIEWS AND REPORTS (2017)
It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research
Ruth Perets et al.
CANCER RESEARCH (2016)
YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells
G. Hua et al.
ONCOGENE (2016)
Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium
Laura H. Rodgers et al.
ONCOTARGET (2016)
Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer
Ensaf M. Al-Hujaily et al.
CANCER PREVENTION RESEARCH (2015)
Mutant p53 expression in fallopian tube epithelium drives cell migration
Suzanne M. Quartuccio et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Pax genes: regulators of lineage specification and progenitor cell maintenance
Judith A. Blake et al.
DEVELOPMENT (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Fallopian Tube Intraluminal Tumor Spread From Noninvasive Precursor Lesions
Jonathan G. Bijron et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
Ruth Perets et al.
CANCER CELL (2013)
The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer
Pavla Brachova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia
Sohela Shah et al.
NATURE GENETICS (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
High-throughput chromatin immunoprecipitation for genome-wide mapping of in vivo protein-DNA interactions and epigenomic states
Ronnie Blecher-Gonen et al.
NATURE PROTOCOLS (2013)
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke et al.
NATURE COMMUNICATIONS (2013)
Value of PAX 8 Immunostaining in Tumor Diagnosis: A Review and Update
Nelson G. Ordonez
ADVANCES IN ANATOMIC PATHOLOGY (2012)
Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma
Paulette Mhawech-Fauceglia et al.
GYNECOLOGIC ONCOLOGY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients
X. Li et al.
ONCOGENE (2012)
Genome-Wide Analysis of Androgen Receptor Targets Reveals COUP-TF1 as a Novel Player in Human Prostate Cancer
Ruth Perets et al.
PLOS ONE (2012)
Deconstructing p53 transcriptional networks in tumor suppression
Kathryn T. Bieging et al.
TRENDS IN CELL BIOLOGY (2012)
A Comprehensive Analysis of PAX8 Expression in Human Epithelial Tumors
Anna R. Laury et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Paired Box Gene 5 Is a Novel Tumor Suppressor in Hepatocellular Carcinoma Through Interaction with p53 Signaling Pathway
Weili Liu et al.
HEPATOLOGY (2011)
PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein
C. G. Li et al.
ONCOGENE (2011)
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
Hiu Wing Cheung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas
Celestine S. Tung et al.
MODERN PATHOLOGY (2009)
p21 in cancer: intricate networks and multiple activities
Tarek Abbas et al.
NATURE REVIEWS CANCER (2009)
Expression of Pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas
Daisuke Nonaka et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
p21 inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint
Ande Satyanarayana et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Emerging roles for PAX8 in ovarian cancer and endosalpingeal development
Nathan J. Bowen et al.
GYNECOLOGIC ONCOLOGY (2007)
Congenital hypothyroid female Pax8-deficient mice are infertile despite thyroid hormone replacement therapy
Jens Mittag et al.
ENDOCRINOLOGY (2007)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
Male congenital hypothyroid Pax8(-/-) mice are infertile despite adequate treatment with thyroid hormone
Joachim Wistuba et al.
JOURNAL OF ENDOCRINOLOGY (2007)
The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome
F Medeiros et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
PAX8-peroxisome proliferator-activated receptor gamma (PPAR gamma) disrupts normal PAX8 or PPAR gamma transcriptional function and stimulates follicular thyroid cell growth
AYM Au et al.
ENDOCRINOLOGY (2006)
Cytoplasmic p21Cip1 is involved in ras-induced inhibition of the ROCK/LIMK/cofilin pathway
S Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
KP Olive et al.
CELL (2004)
Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers
ML Carcangiu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2004)
Getting your Pax straight: Pax proteins in development and disease
N Chi et al.
TRENDS IN GENETICS (2002)
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
JMJ Piek et al.
JOURNAL OF PATHOLOGY (2001)
Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells
BHP Zhou et al.
NATURE CELL BIOLOGY (2001)
Share Paper
